At NASDA Winter Policy Conference, USDA says it’s loosening DEA lab testing requirement for hemp, and FDA signals openness to non-pharma CBD products.
An excerpt from the February 21 edition of the Cannabis Wire Daily newsletter.
After a failed push last year, a study commission was instead formed, which voted in December to recommend medical cannabis legalization.
The National Commission on Marijuana, split on adult use legalization, puts the question to the public.
Syngenta, which rejected an acquisition by Monsanto in 2015, is the latest major agriculture company monitoring the newly-legal market.
Lawmakers approved legislation to establish a Medicinal Cannabis Authority that would create licenses for everything from cultivation to consumption spaces.
Despite vocal support from the governor, a Senate committee has tabled the Cannabis Regulation Act.
A proposed rule requiring labor peace agreements has drawn pushback from the legislature but support from some workers.
While Saint Vincent expects a boost in cannabis revenue, US banking hurdles remain a major headache in the Caribbean.
Consumer Brands Association—think Kellogg's, Pepsi, etc.—has created a high-voltage advisory board to frame its advocacy approach.